According to our new research study on “Molecular Quality Controls Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Application, Analyte Type and End User,” the market is expected to reach US$ 372.64 million in 2028 from US$ 184.62 million in 2021; it is estimated to grow at a CAGR of 10.6% during 2021–2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the molecular quality controls market is mainly attributed to the factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.
Molecular quality controls help to monitor the performance of testing procedures. These tests are helpful to achieve critical and accurate diagnostic information. These controls are used to determine transmissible and genetic diseases too. Moreover, the molecular quality controls also help to monitor the performance of nucleic acid testing protocols for healthcare associated infections, viral load assays and sexually transmitted infections. The growth of the molecular quality controls market is attributed to the factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.
Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00005166/
Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann la-Roche Ltd; Abbott; Quidel Corporation; Qnostics; Maine Molecular Controls Inc; Zeptometrix Corporation; Microbiologics, and Seracare Life Sciences are among the leading companies operating in the molecular quality controls market.
Based on application, the molecular quality controls market is segmented into infectious diseases, oncology, genetic testing, and other applications. The infectious diseases segment held the largest share of the market in 2020, whereas the oncology segment is anticipated to register the highest CAGR in the market during the forecast period. Infectious diseases segment is expected to capture significant market share owing to high incidences of infectious disease outbreaks all over the world, technological advancements in molecular diagnostic testing and product developments by the market players. For instance, in 2018, Microbiologics Inc. launched 8 quality control products: Human Papillomavirus (HPV) Control Panel, Vaginal infection Control Panel, Blood Culture (BCID) Control Panel, Enteric Viral Control Panel and others.
Increasing Prevalence of Genetic Diseases
Molecular quality controls are used to detect genetic diseases as these aid in the interpretation of results. Downs Syndrome is a genetic disorder that causes due to abnormal cell division, which results in an extra full or partial copy of chromosome 21. As per the US Centers for Disease Control and Prevention (CDC), every year, around 6,000 newborns in the US suffer from the Down syndrome. As a result, prenatal testing for Down syndrome is increasing in the country.
Most of the inherited cases of breast cancer are associated with mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). As per the American Cancer Society, around 5% to 10% of breast cancer cases are hereditary, as a result of mutated genes passed from parent to children. Growing awareness of breast cancer increases the adoption of genetic testing for hereditary breast cancer.
Further, as per CDC, sickle cell disease (SCD) is a common genetic blood disorder in the US that affects ~70,000 to 100,000 Americans. Further, as per the WHO, 5% of the world population is the carrier of the genes for hemoglobin disorders, such as sickle-cell disease and thalassemia. Thus, the increasing prevalence of such genetic diseases propels the demand for molecular quality controls.
Molecular Quality Controls Market – by Product
- Independent Controls
- Instrument Specific Controls
Molecular Quality Controls Market – by Analyte Type
- Single Analyte Controls
- Multi Analyte Controls
Molecular Quality Controls Market – by Application
- Infectious Diseases
- Genetic Testing
- Other Applications
Molecular Quality Controls Market – by End User
- Clinical Laboratories
- IVD Manufacturers & Contract Research Organizations
- Academic & Research Institutes
- Other End Users
Purchase Full Copy of This report at: https://www.theinsightpartners.com/buy/TIPRE00005166/
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email